Paracetamol Accord

Paracetamol, the active ingredient in Paracetamol Accord, is an analgesic and antipyretic presented as an intravenous solution for intravenous use. It provides effective pain relief and reduces fever in adult patients requiring rapid therapeutic action in clinical settings such as postoperative care or emergency departments.

GNH USA supplies Paracetamol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance, regulatory compliance, and reliable cold‑chain logistics where required. Our distribution network ensures timely delivery to healthcare facilities across Europe, Asia, Africa and the Americas.

Paracetamol is an analgesic and antipyretic used in the management of pain and fever.

- Mild to moderate pain: provides relief of headache, musculoskeletal discomfort, and postoperative pain. - Fever: reduces elevated body temperature in acute febrile states. - Post‑operative pain: facilitates analgesia after surgery when administered intravenously.

Paracetamol administered intravenously may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Nausea: transient feeling of queasiness. - Transient hypotension: brief drop in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Severe skin rash (e.g., Stevens‑Johnson syndrome): rare but potentially life‑threatening dermatologic reaction. - Hepatotoxicity: rare liver injury, especially with overdose or pre‑existing liver disease. - Blood dyscrasias: uncommon hematologic abnormalities such as agranulocytosis.

When using intravenous paracetamol, several safety considerations should be observed. - Renal impairment: monitor kidney function and adjust dosing if necessary. - Hepatic disease: use with caution and assess liver enzymes. - Alcohol use: avoid excessive intake to reduce risk of liver injury. - Concomitant hepatotoxic drugs: assess cumulative risk of liver damage. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Paracetamol can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other paracetamol‑containing products: risk of overdose and hepatotoxicity. - Strong CYP450 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: paracetamol may enhance anticoagulant effect, requiring INR monitoring. - Alcohol: combined use increases risk of liver injury. - Isoniazid: additive hepatotoxic potential, monitor liver function.